首页> 美国卫生研究院文献>Oxford Open >209. Impact of a Risk-based CAP Prescribing Guideline Paired with Antimicrobial Stewardship to Improve Antibiotic Prescribing for Patients at Low Risk for Drug-Resistant Pathogens
【2h】

209. Impact of a Risk-based CAP Prescribing Guideline Paired with Antimicrobial Stewardship to Improve Antibiotic Prescribing for Patients at Low Risk for Drug-Resistant Pathogens

机译:209.基于风险的CAP处方指南与抗菌素管理相结合对改善耐药耐药病原体低风险患者的抗生素处方的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundAntimicrobial stewardship programs (ASPs) reduce the burden of multidrug-resistant organisms and improve antibiotic prescribing. Concerns about drug-resistant pathogens (DRPs) in community-acquired pneumonia (CAP) lead to over-prescribing of broad-spectrum antibiotics, and ASP interventions to improve CAP prescribing are not well defined. In 2017, our hospital implemented a CAP guideline for patients at low risk for DRPs along with ASP support. The purpose of this study was to evaluate the impact of the guideline with ASP support on CAP-specific antibiotic prescribing.
机译:背景抗菌素管理计划(ASP)减轻了耐多药生物的负担并改善了抗生素处方。对社区获得性肺炎(CAP)中耐药性病原体(DRP)的担忧导致广谱抗生素的处方过多,而改善CAP处方的ASP干预措施尚未明确。 2017年,我们医院针对DRP低危患者以及ASP支持实施了CAP指南。这项研究的目的是评估ASP支持指南对CAP特定抗生素处方的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号